Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein B gene mutations affecting cholesterol levels.

R V Farese1, M F Linton, S G Young

  • 1Gladstone Foundation Laboratories for Cardiovascular Disease, Department of Medicine, University of California, San Francisco.

Journal of Internal Medicine
|June 11, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

Taming the sphinx: Mechanisms of cellular sphingolipid homeostasis.

Biochimica et biophysica acta·2016
Same author

Heterogeneity in the properties of mutant secreted lymphocyte antigen 6/urokinase receptor-related protein 1 (SLURP1) in Mal de Meleda.

The British journal of dermatology·2015
Same author

Stable isotope imaging of biological samples with high resolution secondary ion mass spectrometry and complementary techniques.

Methods (San Diego, Calif.)·2014
Same author

Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.

Lupus·2012
Same author

Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.

Journal of internal medicine·2012

Mutations in the apolipoprotein B (apoB) gene cause familial hypobetalipoproteinaemia, leading to low LDL cholesterol. A specific mutation, familial defective apolipoprotein B (FDB), results in high cholesterol due to impaired LDL receptor binding.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiovascular Science
  • Metabolic Disorders

Background:

  • Apolipoprotein B (apoB) gene mutations significantly impact plasma cholesterol levels.
  • Over 20 apoB gene mutations cause familial hypobetalipoproteinaemia, characterized by low apoB and LDL cholesterol.
  • Most mutations lead to truncated apoB protein, affecting LDL metabolism.

Purpose of the Study:

  • To review mutations in the apolipoprotein B gene affecting plasma cholesterol.
  • To describe familial hypobetalipoproteinaemia and familial defective apolipoprotein B (FDB).
  • To highlight the clinical and genetic aspects of apoB gene mutations.

Main Methods:

  • Literature review of apoB gene mutations and their effects on cholesterol.
  • Analysis of clinical phenotypes associated with familial hypobetalipoproteinaemia and FDB.

Related Experiment Videos

  • Description of molecular mechanisms, including impaired LDL receptor binding.
  • Main Results:

    • Familial hypobetalipoproteinaemia heterozygotes have significantly reduced LDL cholesterol and are usually asymptomatic.
    • Homozygotes for familial hypobetalipoproteinaemia exhibit extremely low LDL cholesterol with variable clinical presentations.
    • Familial defective apolipoprotein B (FDB), caused by an Arg3500Gln substitution, impairs LDL clearance and causes hypercholesterolaemia, affecting up to 1 in 500 individuals in some populations.

    Conclusions:

    • ApoB gene mutations are a significant cause of dyslipidaemia, leading to both hypobetalipoproteinaemia and hypercholesterolaemia.
    • Understanding these mutations is crucial for diagnosing and managing cholesterol-related disorders.
    • The FDB mutation highlights the critical role of apoB in LDL receptor interaction and cholesterol homeostasis.